Japan’s Perilous New Pricing Policy
The introduction of a new drug pricing reform in Japan has pharma up in arms. Are their fears justified?
Close log in window
Data generating devices may seem gimmicky, but they are poised to transform healthcare
If pharma is to keep whizzing ahead, it needs to rethink its approach to market access
Patient recruitment for clinical trials is commonly accepted to be a herculean task. A new platform could make the process a lot quicker and...
RWE continues to animate expectations far and wide, but its success calls for level-headed pragmatism
